ATE185274T1 - Therapeutisches mittel gegen drohenden abortus - Google Patents

Therapeutisches mittel gegen drohenden abortus

Info

Publication number
ATE185274T1
ATE185274T1 AT93103300T AT93103300T ATE185274T1 AT E185274 T1 ATE185274 T1 AT E185274T1 AT 93103300 T AT93103300 T AT 93103300T AT 93103300 T AT93103300 T AT 93103300T AT E185274 T1 ATE185274 T1 AT E185274T1
Authority
AT
Austria
Prior art keywords
therapeutic agent
abortion
agent against
against risk
blood coagulation
Prior art date
Application number
AT93103300T
Other languages
English (en)
Inventor
Takaaki Nakaya
Yayoi Kajiwara
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Application granted granted Critical
Publication of ATE185274T1 publication Critical patent/ATE185274T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT93103300T 1992-03-06 1993-03-02 Therapeutisches mittel gegen drohenden abortus ATE185274T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP04935392A JP3337488B2 (ja) 1992-03-06 1992-03-06 切迫流産治療剤

Publications (1)

Publication Number Publication Date
ATE185274T1 true ATE185274T1 (de) 1999-10-15

Family

ID=12828657

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93103300T ATE185274T1 (de) 1992-03-06 1993-03-02 Therapeutisches mittel gegen drohenden abortus

Country Status (11)

Country Link
US (1) US5554593A (de)
EP (1) EP0559145B1 (de)
JP (1) JP3337488B2 (de)
KR (1) KR100255095B1 (de)
AT (1) ATE185274T1 (de)
AU (1) AU657839B2 (de)
CA (1) CA2091134C (de)
DE (1) DE69326627T2 (de)
DK (1) DK0559145T3 (de)
ES (1) ES2138602T3 (de)
GR (1) GR3032224T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642433B1 (en) 1997-05-15 2003-11-04 Trillium Therapeutics Inc. Fgl-2 knockout mice
ATE339964T1 (de) * 1997-05-15 2006-10-15 Trillium Therapeutics Inc Verfahren um immunkoagulation zu modulieren
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US8182840B2 (en) 2005-09-27 2012-05-22 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
ES2822301T3 (es) 2011-06-10 2021-04-30 Tissuetech Inc Métodos de procesamiento de tejidos de soporte fetal
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
JP2018516869A (ja) 2015-05-20 2018-06-28 ティッシュテック，インク． 上皮細胞の増殖および上皮間葉転換を防ぐための組成物および方法
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
JPH03240738A (ja) * 1990-02-20 1991-10-28 Hoechst Japan Ltd 糖尿病性壊疽治療剤

Also Published As

Publication number Publication date
DE69326627T2 (de) 2000-02-17
EP0559145B1 (de) 1999-10-06
KR100255095B1 (ko) 2000-05-01
DK0559145T3 (da) 2000-04-10
AU657839B2 (en) 1995-03-23
US5554593A (en) 1996-09-10
AU3401093A (en) 1993-09-09
KR930019224A (ko) 1993-10-18
ES2138602T3 (es) 2000-01-16
EP0559145A1 (de) 1993-09-08
DE69326627D1 (de) 1999-11-11
JPH05246886A (ja) 1993-09-24
GR3032224T3 (en) 2000-04-27
CA2091134A1 (en) 1993-09-07
CA2091134C (en) 2004-04-06
JP3337488B2 (ja) 2002-10-21

Similar Documents

Publication Publication Date Title
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
ATE358505T1 (de) Beschichtete endovaskuläre vorrichtung
CY1105834T1 (el) Χρηση παρασκευασματων για την εφαρμογη, στον κατω αναπνευστικο σωληνα αντισηπτικων παραγοντων και/ή παραγοντων που προαγουν την επουλωση των πληγων
BR0109446A (pt) Medicamento para a aplicação intracorpórea, uso de um xanteno halogenado, composição farmacêutica, e, método de tratamento
KR920019342A (ko) 골질환 치료제
NO20034684L (no) Mikroprojeksjonsanordning med belegg inneholdende et fordelaktig middel
ATE515265T1 (de) Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen
DE69814394D1 (de) Verwendung von levobupivacain
ES2173111T3 (es) Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
FI935693A7 (fi) Bifenyylin johdannaiset, niiden valmistus ja käyttö korkean verenpaineen ja sydäntautien hoitoon
ATE185274T1 (de) Therapeutisches mittel gegen drohenden abortus
DE3875866D1 (de) Sulfonamidolphenyl-derivate und diese enthaltende therapeutische und vorbeugend wirkende mittel gegen arrhythmie.
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
DE68926746D1 (de) Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel
ATE316379T1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
DK0588477T3 (da) Medicinsk præparat omfatende TCF-11
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
EP0950416A4 (de) Preventiver und/oder therapeutischer Wirkstoffgegen Cachexia
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
CY1106702T1 (el) Χρηση ενος συνδυασμου μιας πουρινης και ενος παραγοντα δοτη μονοξειδιου του αζωτου για την προληψη ή την αγωγη γενετησιων δυσλειτουργιων
BR0104586A (pt) Método para tratamento de neurodegeneração
ES2182840T3 (es) Factor xiii para el tratamiento de heridas de la piel.
TWI263502B (en) Pharmaceutical preparation for treating ischemic disease of heart or limbs
NO953003L (no) Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater
NO890997D0 (no) Applikator for hudrensemiddel, hudpleiemiddel og medisinsk salve.